A new HLA-DRB allele (DRB1*15014) identified in a Caucasian individual.

Hum Immunol

Department of Transplantation Immunology, Institute of Immunology, University of Heidelberg, Germany.

Published: February 2003

Polymerase chain reaction with sequence specific primers subtyping of a DRB1*15 allele in a male 11-year-old German Caucasian and his father revealed a reaction pattern that did not agree with any known specificity, thus suggesting the existence of a novel allele. Sequence-based typing after allelic separation revealed the new allele human leukocyte antigen (HLA)-DRB1*15014. The sequence pattern of HLA-DRB1*15014 might have been generated as a result of two independent recombinations, most likely over several generations.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0198-8859(02)00779-6DOI Listing

Publication Analysis

Top Keywords

hla-drb allele
4
allele drb1*15014
4
drb1*15014 identified
4
identified caucasian
4
caucasian individual
4
individual polymerase
4
polymerase chain
4
chain reaction
4
reaction sequence
4
sequence specific
4

Similar Publications

Article Synopsis
  • Scientists are studying a disease called cystic echinococcosis (CE) to understand how it affects humans and why some people get it and others don't.
  • They looked at specific genes (HLA class II) in patients to see if there was a connection between these genes and different stages of the disease.
  • The study found that a certain gene (HLA-DRB1*03) was less common in sick people than in healthy ones, suggesting it might help protect against CE, but more research is needed to be sure.
View Article and Find Full Text PDF

A key unmet need in the management of hemophilia A (HA) is the lack of clinically validated markers that are associated with the development of neutralizing antibodies to Factor VIII (FVIII) (commonly referred to as inhibitors). This study aimed to identify relevant biomarkers for FVIII inhibition using Machine Learning (ML) and Explainable AI (XAI) using the My Life Our Future (MLOF) research repository. The dataset includes biologically relevant variables such as age, race, sex, ethnicity, and the variants in the gene.

View Article and Find Full Text PDF

Prediction of HLA genotypes from single-cell transcriptome data.

Front Immunol

September 2023

Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Stanford, CA, United States.

The human leukocyte antigen (HLA) locus plays a central role in adaptive immune function and has significant clinical implications for tissue transplant compatibility and allelic disease associations. Studies using bulk-cell RNA sequencing have demonstrated that HLA transcription may be regulated in an allele-specific manner and single-cell RNA sequencing (scRNA-seq) has the potential to better characterize these expression patterns. However, quantification of allele-specific expression (ASE) for HLA loci requires sample-specific reference genotyping due to extensive polymorphism.

View Article and Find Full Text PDF

Quantitative and causal analysis for inflammatory genes and the risk of Parkinson's disease.

Front Immunol

March 2023

Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.

Background: The dysfunction of immune system and inflammation contribute to the Parkinson's disease (PD) pathogenesis. Cytokines, oxidative stress, neurotoxin and metabolism associated enzymes participate in neuroinflammation in PD and the genes involved in them have been reported to be associated with the risk of PD. In our study, we performed a quantitative and causal analysis of the relationship between inflammatory genes and PD risk.

View Article and Find Full Text PDF

Non-small-cell lung cancer (NSCLC) is the most common lung cancer which has the highest mortality rate in Indonesia. One of the trends in treating cancer is by utilizing peptide vaccines, an immunotherapeutic approach that aims to stimulate the cell-mediated adaptive immune system to recognize cancer-associated peptides. Currently, no peptide vaccines are available in the market for NSCLC treatment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!